Showing results (91-100 of 113) with videos related to
Sort By:
Pageof 12
Journal of Medicinal Chemistry|June 29, 2012
Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivoEnza Lacivita, Daniela Patarnello, Nikolas Stroth, et al.Organic & Biomolecular Chemistry|December 6, 2024
Purine nucleosides as selective inhibitors of butyrylcholinesterase - a multidisciplinary studyVasco Cachatra, Alice Martins, Maria Conceição Oliveira, et al.European Journal of Medicinal Chemistry|September 9, 2019
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversersElisabetta Teodori, Marialessandra Contino, Chiara Riganti, et al.European Journal of Medicinal Chemistry|April 5, 2019
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulatorsSilvia Dei, Laura Braconi, Alfonso Trezza, et al.Pharmaceuticals (Basel, Switzerland)|June 26, 2019
Design and Synthesis of CNS-targeted Flavones and Analogues with Neuroprotective Potential Against H2O2- and Aβ1-42-Induced Toxicity in SH-SY5Y Human Neuroblastoma CellsAna M de Matos, Alice Martins, Teresa Man, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 17, 2026
Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammationImane Ghafir El Idrissi, David Moreira Alvarez, Rocío Piña Márquez, et al.Frontiers in Oncology|March 6, 2023
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell linesAnnalisa Schirizzi, Marialessandra Contino, Livianna Carrieri, et al.European Journal of Medicinal Chemistry|January 20, 2020
Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R)Francesco Spinelli, Roberta Giampietro, Angela Stefanachi, et al.Bioorganic Chemistry|July 10, 2026
Virtual screening-guided repurposing of fluorescent probes to detect EGFR expression in renal cellsGiovanni Graziano, Daniela Trisciuzzi, Marialessandra Contino, et al.Journal of Experimental & Clinical Cancer Research : CR|July 15, 2025
CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistanceAnnalisa Schirizzi, Natasha Renna, Giampiero De Leonardis, et al.Pageof 12